Navigation Links
Delaware Man Spearheads Brain Tumor Awareness
Date:9/29/2008

as senior vice-president to start the Foundation.

"Twenty-five years ago, we knew very little about breast cancer," Grundner points out. "In memory of my late wife and best friend Kelly, I'm working to make brain tumors as familiar in the future as breast cancer is today, and this campaign in Delaware is just the start."


'/>"/>
SOURCE The Kelly Heinz-Grundner Brain Tumor Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
2. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
3. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
4. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
5. OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
6. Revealing the regulating mechanism behind signal transduction in the brain
7. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
8. Towards zero training for brain-computer interfacing
9. Roche and Response Biomedical Corporation Aim to Reduce Vein-to-Brain Time with New Point-of-Care Cardiac Tests
10. New map IDs the core of the human brain
11. Detecting dangerous chemicals with lasers, exploring the brains circuitry with light and more
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... Md. , Dec. 17, 2014 CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a primary commercial focus ... it has been granted a Type C meeting with ... the meeting will be held in February 2015.  During ...
(Date:12/15/2014)... Israel , Dec. 15, 2014 /PRNewswire/ ... a leading developer of adult stem cell technologies for ... Therapeutics Ltd. was awarded a grant of approximately $1.1 ... the Chief Scientist (OCS).  This is the eighth year ... from the Office of the Chief Scientist, which is ...
(Date:12/15/2014)... COPENHAGEN, Denmark , Dec. 15, 2014 /PRNewswire/ ... its innovative TransCon technology to address significant unmet ... from its ongoing Phase 2 pediatric study to ... growth hormone deficiency, or GHD.  This interim analysis ... the anticipated total enrollment in the study, completing ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
... the Annual Report to the Nation on the Status ... deaths for many types of cancers. This encouraging news can ... smoking and improved diet, and early detection. ... the blood cancers, early detection is rare, there are no ...
... Neb., April 1, 2011 Transgenomic, Inc. ... have completed studies employing the company,s high-sensitivity cancer ... and BLOCker™-Sequencing.  Results from these studies will be ... (AACR) meeting in Orlando, Florida, April 2-6, 2011. ...
... NY As part of the quest to form ... electronic, and medical devices, researchers at the U.S. Department ... molecules in thin films remain frozen at a temperature ... have a range of applications extending from organic solar ...
Cached Biology Technology:The Leukemia & Lymphoma Society: Accelerating Cures Must Be a Priority 2Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting 2Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting 3Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting 4Expanding the degrees of surface freezing 2
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
(Date:11/21/2014)... Nov. 20, 2014 C-Labs LLC, a leading ... of Things (IoT), today announced the appointment of ... officer. Previously a strategic advisor to the firm, Mr. ... Mr. Traynor is based out of the C-Labs office ... to Chris Muench , Chief Executive Officer. ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... been found to negatively affect these teenagers health in ... and cancers of the reproductive system. Given these findings, ... at increased risk for early puberty in order to ... youths., New research shows that greater support from mothers ...
... -- In response to the need for localized efforts ... threatened staghorn coral, Diego Lirman, Ph.D., and James Herlan, ... Marine and Atmospheric Science (RSMAS) have established an ... The goals of the coral nursery are to ...
... Inc.,(Pink Sheets: ESMT) ("e-Smart" or the "Company") responds ... in which a series of serious allegations,are made ... as untrue, inaccurate and misleading. IDsmart is operated ... plead guilty to,securities fraud charges in the U.S. ...
Cached Biology News:Family conditions may affect when girls experience puberty 2New south Florida nursery to focus on staghorn corals 2e-Smart Technologies Responds to Press Release Issued By IDsmart LLC 2e-Smart Technologies Responds to Press Release Issued By IDsmart LLC 3
Glutamate Receptor 5/1a...
... to Asparagine synthetase ( Abpromise ... Antigen: ... in the C-terminus of Human ... Entrez GeneID: 440 ...
Shh Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Anti-human C5/C5b, Clone 568, Monoclonal Antibody...
Biology Products: